Scientific program
Preliminary program – Tuesday, November 22, 2022
9:00–10:30 am
Live Session I
Of CARs and TRUCKs: Redirected T cells for the adoptive immunotherapy
Keynote: Abken, Hinrich (RCI – University of Regensburg, Regensburg, Germany)
NK cells as "CAR" drivers – current status and future developments
Keynote: Tonn, Torsten (Technical University of Dresden, Faculty of Medicine Carl Gustav Carus, Dresden, Germany)
10:30–10:45 am
Break
10:45-11:15 am
Industry Flash Talk
11:15–11:30 am
Break
11:30 am – 12:30 pm
Poster Session I
12:30–1:00 pm
Break
1:00-1:45 pm
Industry sponsored session
1:45-2:15 pm
Break
2:15-3:45 pm
Live Session II
TCR-engineered cells for cancer immunotherapy
Keynote: Olweus, Johanna (Oslo University Hospital, Oslo, Norway)
TCR-T Cell Therapy
Keynote: Thomas, Simone (RCI Regensburg Center for Interventional Immunology, Regensburg, Germany)
3:45-4:00 pm
Break
4:00-5:00 pm
Poster Session II
Preliminary program – Wednesday, November 23, 2022
9:00–10:30 am
Live Session III
CAR-T cells and solid tumors / Increasing the therapeutic index of CAR-T cells in solid tumors
Keynote: Guedan, Sonia (August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain)
The clinical implementation of immunotherapies in the treatment of gastrointestinal cancers
Keynote: Smyth, Elizabeth (Cambridge University Hospitals NHS Foundation Trust, Cambridge, Great Britain)
10:30–10:45 am
Break
10:45-11:15 am
Industry Flash Talk
11:15–11:30 am
Break
11:30 am – 12:30 pm
Poster Session III
12:30–1:00 pm
Break
1:00-1:45 pm
Industry sponsored session
1:45-2:15 pm
Break
2:15-3:45 pm
Live Session IV
Vaccine-based approaches / mRNA therapeutics in cancer immunotherapy
Keynote: Rengstl, Benjamin (BioNTech SE, Mainz, Germany)
Virus-free aROR1-CAR-T cells
Keynote: Hudecek, Michael (Universitätsklinikum Würzburg, Würzburg, Germany)
Further keynotes have been requested.
Archive
Scientific program 2021 – Download [PDF]
